Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

NCT06448793 · clinicaltrials.gov ↗

RECRUITING

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG: Approved Non-small Cell Lung Cancer (NSCLC) therapies

Sponsor

Bristol-Myers Squibb